Drugs@FDA document
CARBAGLU Letter · NDA 022562 SUPPL-8
Drugs@FDA document · RECORDATI RARE · Jan 25, 2021
Key facts
| Drug name | CARBAGLU |
|---|---|
| Document type | Letter |
| Application | NDA022562 |
| Submission | SUPPL-8 |
| Company | RECORDATI RARE |
| Document date | Jan 25, 2021 |
At a glance
- Efficacy-New Indication Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: